Bank of Montreal’s Repros Therapeutics Inc. RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-1,000
| Closed | -$1K | – | 4542 |
|
|
2017
Q4 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 4144 |
|
|
2017
Q3 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 4516 |
|
|
2017
Q2 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 4471 |
|
|
2017
Q1 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 3940 |
|
|
2016
Q4 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 3939 |
|
|
2016
Q3 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 3905 |
|
|
2016
Q2 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 3952 |
|
|
2016
Q1 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 4164 |
|
|
2015
Q4 | $1K | Sell |
1,000
-250
| -20% | -$802 | ﹤0.01% | 4188 |
|
|
2015
Q3 | $9K | Buy |
1,250
+250
| +25% | +$1.91K | ﹤0.01% | 3523 |
|
|
2015
Q2 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 3582 |
|
|
2015
Q1 | $9K | Sell |
1,000
-1
| -0.1% | -$9 | ﹤0.01% | 3541 |
|
|
2014
Q4 | $10K | Sell |
1,001
-4,999
| -83% | -$42.6K | ﹤0.01% | 3574 |
|
|
2014
Q3 | $60K | Buy |
6,000
+3,630
| +153% | +$53.7K | ﹤0.01% | 3068 |
|
|
2014
Q2 | $41K | Sell |
2,370
-11,355
| -83% | -$185K | ﹤0.01% | 3298 |
|
|
2014
Q1 | $244K | Buy |
13,725
+11,425
| +497% | +$221K | ﹤0.01% | 2421 |
|
|
2013
Q4 | $42K | Sell |
2,300
-1,400
| -38% | -$26.4K | ﹤0.01% | 2949 |
|
|
2013
Q3 | $99K | Buy |
3,700
+2,700
| +270% | +$57.9K | ﹤0.01% | 2517 |
|
|
2013
Q2 | $18K | Buy |
+1,000
| New | +$17.7K | ﹤0.01% | 3136 |
|
Bank of Montreal's RPRX Position: Q1 2018 in Review
Bank of Montreal sold out of Repros Therapeutics Inc. (RPRX) in Q1 2018, closing a stake of 1,000 shares — an estimated $1K sold.
Bank of Montreal first reported a position in RPRX in Q2 2013 and held it in 19 quarters. The position peaked at $244K in Q1 2014. 1 fund tracked by Wall St. Rank holds RPRX as of Q1 2018.
- Bank of Montreal reported no remaining Repros Therapeutics Inc. position as of Q1 2018 after selling out during the quarter.
- Bank of Montreal sold 1,000 Repros Therapeutics Inc. shares in Q1 2018, an estimated $1K.
- Bank of Montreal first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 19 quarters.
- Bank of Montreal's Repros Therapeutics Inc. position peaked at $244K in Q1 2014.
- 1 fund tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q1 2018.
Based on Bank of Montreal's 13F filing for Q1 2018, filed 13 Apr 2018.